Deal Watch: Roche Terminates Gene Therapy Alliance, Partners In IBD With Synlogic

28 Jun 2021

Roche gives back choroideremia candidate to 4D Molecular after reviewing Phase I data, partners on synthetic GI therapy with Synlogic. AbbVie opts to acquire TeneoOne under 2019 agreement.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.

Undoing a gene therapy delivery alliance inked in 2015, 4D Molecular Therapeutics LLC announced on 24 June that it...